跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack
Approved
STANDARD
RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack
Medsurge Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
a3dbf6edd350b346
Company
Medsurge Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
a3dbf6edd350b346
Product Name
RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack
Artg Id
220023
Artg Name
RIZATRIPTAN-AU rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack
Sponsor
Medsurge Pharma Pty Ltd
Company Detail Path
/organization/medsurge-pharma-pty-ltd
Artg Date
2015-02-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/98b63b46c43bac474b2b74f0dee9dfe9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/68df1c44a5ca838a1ceaf85f6f285831.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
a3dbf6edd350b346
Type
Standard
Back to TGA Approvals